|
Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study.
BMJ. 2006 Oct; 333:7571-726. Epub 2006 Sep 19
Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Andersen M, Lassen AT. |
|
Haemostatic Factors and the Risk of Cardiovascular Death in Patients With Coronary Artery Disease. The AtheroGene Study.
Arterioscler Thromb Vasc Biol. 2006 Oct; Epub ahead of print Sep
Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, Lackner KJ, Cambien F, Blankenberg S, Tiret L. |
|
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial
Am Heart J. 2006 Oct; 152(4):627-35.
Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E; TRITON-TIMI 38 Investigators. |
|
The Effect of Novel Cardiovascular Risk Factors on the Ethnic-Specific Odds for Peripheral Arterial Disease in the Multi-Ethnic Study of Atherosclerosis (MESA).
J Am Coll Cardiol. 2006 Sep; 48(6):1190-7. Epub 2006 Aug 28 Sep
Allison MA, Criqui MH, McClelland RL, Scott JM, McDermott MM, Liu K, Folsom AR, Bertoni AG, Sharrett AR, Homma S, Kori S. |
|
Usefulness of Clopidogrel in Abolishing the Increased Risk of Reinfarction Associated With Higher Platelet Counts in Patients With ST-Elevation Myocardial Infarction (Results from CLARITY-TIMI 28).
Am J Cardiol. 2006 Sep; 98(6):761-3. Epub 2006 Aug 2 Sep
Gibson CM, Ly HQ, Murphy SA, Ciaglo LN, Southard MC, Stein EB, Buros JL, Sabatine MS, Cannon CP; TIMI Study Group. |
|
Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28).
Am J Cardiol. 2006 Sep; 98(6):761-3. Epub 2006 Ago 2
Gibson CM, Ly HQ, Murphy SA, Ciaglo LN, Southard MC, Stein EB, Buros JL, Sabatine MS, Cannon CP; TIMI Study Group. |
|
Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study.
Eur Heart J. 2006 Sep; 27(17):2046-53. Epub 2006 Ago 9
Collins P, Flather M, Lees B, Mister R, Proudler AJ, Stevenson JC. |
|
Travel-Related Venous Thrombosis: Results from a Large Population-Based Case Control Study (MEGA Study).
PLoS Med. 2006 Ago; 3(8) Epub ahead of print Ago
Cannegieter SC, Doggen CJ, van Houwelingen HC, Rosendaal FR. |
|
Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002.
J Vasc Surg. 2006 Ago; 44(2):319-24.
Lane JS, Vittinghoff E, Lane KT, Hiramoto JS, Messina LM. |
|
Gentamicin induces sub-therapeutic levels of coagulation factor VII in patients with nonsense mutations. THE INTERNATIONAL FACTOR VII DEFICIENCY STUDY GROUP.
J Thromb Haemost. . 2006 Ago; 4(8):1828-30.
Pinotti M, Rizzotto L, Chuansumrit A, Mariani G, Bernardi F; International Factor VII Deficiency Study Group. |
|
A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma.
Blood. 2006 Jul; Epub ahead of print Abr
Kerkhoffs JL, Eikenboom JC, Schipperus MS, van Wordragen-Vlaswinkel J, Brand R, Harvey MS, de Vries RR, Barge R, van Rhenen DJ, Brand A. |
|
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation. The Rotterdam Study 1990-1999.
J Thromb Haemost. 2006 Jul; Epub ahead of print Abr
Heeringa J, Conway DS, Van der Kuip DA, Hofman A, Breteler MM, Lip GY, Witteman JC. |
|
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.
J Am Coll Cardiol. 2006 Jul; 48(1):37-42. Epub 2006 Jun 12
Scirica BM, Sabatine MS, Morrow DA, Gibson CM, Murphy SA, Wiviott SD, Giugliano RP, McCabe CH, Cannon CP, Braunwald E. |
|
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.
J Am Coll Cardiol. 2006 Jul; 48(1):37-42. Epub 2006 Jun 12 Jun
Scirica BM, Sabatine MS, Morrow DA, Gibson CM, Murphy SA, Wiviott SD, Giugliano RP, McCabe CH, Cannon CP, Braunwald E. |
|
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
Lancet. 2006 Jun; 367(9526):1903-12.
ACTIVE Writing Group on behalf of the ACTIVE Investigators; Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. |
|
MATCH results: implications for the internist.
Am Heart J. 2006 Jun; 119(6):526-e1-7.
Lutsep HL. |
|
Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study.
Postgrad Med J. 2006 Jun; 82(968):404-10.
Serebruany VL, Midei MG, Meilman H, Malinin AI, Lowry DR. |
|
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
Lancet. 2006 May; 367(9523):1665-73.
ESPRIT Study Group; Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. |
|
Aspirin or Anticoagulants in Stenosis of the Middle Cerebral Artery: A Randomized Trial.
Cerebrovasc Dis. 2006 May; 22(2-3):162-169.
Marti-Fabregas J, Cocho D, Marti-Vilalta JL, Gich I, Belvis R, Bravo Y, Millan M, Castellanos M, Rodriguez-Campello A, Egido J, Geffner D, Gil-Nunez A, Marta J, Navarro R, Obach V, Palomeras E. |
|
A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trial.
Eur Heart J. 2006 May;
Rasoul S, Ottervanger JP, de Boer MJ, Miedema K, Hoorntje JC, Gosselink M, Zijlstra F, Suryapranata H, Dambrink JH, Van´t Hof AW. |
